Skip to main content

Critical issues in delivery of RNAi therapeutics in vivo.

Publication ,  Journal Article
Rivera, S; Yuan, F
Published in: Current pharmaceutical biotechnology
June 2012

RNA interference (RNAi) is a fundamental mechanism of gene regulation and has been harnessed to produce a new class of drugs for treatment of various diseases. A key issue in these applications is how to effectively deliver RNAi therapeutics into target cells. This review is focused on advances in RNA delivery in vivo. To achieve it, novel strategies have been developed to enhance stability of RNA in cells and tissues, overcome barriers to transport of RNA or its carriers in the body, and reduce immunogenicity and cytotoxicity of treatment. Approaches to RNA delivery are divided into three categories in this review: biological, chemical, and physical. Advantages and disadvantages of each method are discussed. At present, effective delivery of RNAi therapeutics in vivo is still a challenge although significant advances have been made in this field.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Current pharmaceutical biotechnology

DOI

EISSN

1873-4316

ISSN

1389-2010

Publication Date

June 2012

Volume

13

Issue

7

Start / End Page

1279 / 1291

Related Subject Headings

  • RNA, Small Interfering
  • RNA Interference
  • Humans
  • Genetic Therapy
  • Drug Delivery Systems
  • Biotechnology
  • Animals
  • 3214 Pharmacology and pharmaceutical sciences
  • 3206 Medical biotechnology
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rivera, S., & Yuan, F. (2012). Critical issues in delivery of RNAi therapeutics in vivo. Current Pharmaceutical Biotechnology, 13(7), 1279–1291. https://doi.org/10.2174/138920112800624300
Rivera, Stephanie, and Fan Yuan. “Critical issues in delivery of RNAi therapeutics in vivo.Current Pharmaceutical Biotechnology 13, no. 7 (June 2012): 1279–91. https://doi.org/10.2174/138920112800624300.
Rivera S, Yuan F. Critical issues in delivery of RNAi therapeutics in vivo. Current pharmaceutical biotechnology. 2012 Jun;13(7):1279–91.
Rivera, Stephanie, and Fan Yuan. “Critical issues in delivery of RNAi therapeutics in vivo.Current Pharmaceutical Biotechnology, vol. 13, no. 7, June 2012, pp. 1279–91. Epmc, doi:10.2174/138920112800624300.
Rivera S, Yuan F. Critical issues in delivery of RNAi therapeutics in vivo. Current pharmaceutical biotechnology. 2012 Jun;13(7):1279–1291.

Published In

Current pharmaceutical biotechnology

DOI

EISSN

1873-4316

ISSN

1389-2010

Publication Date

June 2012

Volume

13

Issue

7

Start / End Page

1279 / 1291

Related Subject Headings

  • RNA, Small Interfering
  • RNA Interference
  • Humans
  • Genetic Therapy
  • Drug Delivery Systems
  • Biotechnology
  • Animals
  • 3214 Pharmacology and pharmaceutical sciences
  • 3206 Medical biotechnology
  • 1115 Pharmacology and Pharmaceutical Sciences